Atlas Trials

Xeloda and Bevacizumab to Treat Rectal Cancer

Clinical trial NCT00847119 · COMPLETED

Trial details

NCT number
NCT00847119
Sponsor
Institut Català d'Oncologia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2007-09-01
Primary completion
2011-06-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.